Introduction
CD23 is a 45 kDa type II transmembrane glycoprotein which functions as the low affinity receptor for IgE expressed on haematopoietic cells. [1] [2] [3] In the human, CD23 is encoded by a single, eleven-exon gene spanning 13 Kb located at chromosome 19p13 adjacent to the DC-SIGN and DC-SIGNR genes. 4, 5 The gene gives rise to two protein isoforms, CD23a and CD23b, which differ by only six or seven amino acids in their extreme cytoplasmic Ntermini. 6, 7 The generation of the two isoforms reflects cell type-specific utilisation of transcriptional initiation sites and differential splicing of RNA transcripts 6 ( Figure 1 ). Three mRNA species are generated, with one giving rise to the CD23a protein isoform and two others, differing only in the 5Ј non-coding region, programming the synthesis of the CD23b isoform. Thus, CD23a is constitut- Figure 1 The CD23 gene and generation of reporter constructs. The top line illustrates the layout of exons I-III at the 5Ј end of the CD23 gene with non-coding (open rectangles) and coding (filled rectangles) illustrated; exons IV to XI are not shown, and lie 3Ј to exon III. CD23a transcripts contain exons I, II and III-XI, while CD23b transcripts comprise exons b and III-XI. 6 The 400-600 bp sequences lying immediately upstream of the transcription initiation sites for the CD23a and CD23b transcripts are shown, with transcription factor binding sites denoted as follows: STAT6 sites, tall, filled rectangles; NF-B, long flat rectangles; Glucocorticoid response elements (GRE) ively expressed at low levels exclusively in B cells, while the CD23b isoform is expressed in a range of haematopoietic cell types, including T and B cells, monocytic cells and polymorphonuclear leukocytes, 8 following activation by a range of stimuli. 6 Few studies have focussed upon the function of regulatory elements which lie immediately proximal to the transcription initiation sites immediately upstream of the CD23a and CD23b coding sequences, ie, 5Ј to exons I and b respectively, in the CD23 gene (Figure 1 ). There are studies of the involvement of Epstein-Barr virus-encoded proteins in regulation of CD23 expression, but these are mediated via enhancer elements located some distance from the transcription initiation sites or in intron 1. 9, 10 Recent data have also shown that the Ku autoantigen binds to a EBV-responsive enhancer in intron 1 of the CD23 gene. 10 Inspection of the sequences in the those flanking regions close to the transcription initiation sites reveals good candidate sites for a range of transcriptional regulatory factors which, in turn, are likely targets for signalling pathways linked to receptors known to influence CD23 expression. Thus, both CD23a and CD23b promoters contain canonical STAT6 binding sites (TT-N 6 -AA), 11 and at least one of these elements is a defined IL-4 response element (IL4RE). 12, 13 Similarly, sequences constituting NF-B binding sites (GGRNNNYYCC 14 ) are also found in both CD23a and CD23b upstream regions, while nucleotide elements which might serve to bind BSAP/pax-5 (RNNCANTGNNGCGKRACSR 15 ) are found only in the upstream region of the CD23a promoter, and candidate AP1 binding sites (TGASTCA 16, 17 ) are unique to the CD23b flanking region. The effect of external stimulation of tonsillar B cells bearing transiently-transfected reporter constructs controlled by sequences lying 400-600 base pairs upstream of the transcription initiation sites for the CD23a and CD23b mRNAs was assessed. The effect of deletion of putative transcription factor binding sites upon reporter activity was also assessed, and the data are consistent with the conclusion that the CD23a and CD23b promoters respond to discrete extracellular stimuli in completely different ways.
Results
Response patterns of the CD23a and CD23b proximal promoters CD23 expression in B cells can be driven by a range of external stimuli. However, the external domains of the CD23a and CD23b protein isoforms are identical and transcript analysis is required to establish which isoform is expressed. Reporter plasmids containing 300-600 bp from the upstream regions flanking either the CD23a or CD23b transcription start sites were transfected into the P3HR1 B cell line or freshly-isolated tonsillar B cells and the cells stimulated with IL-4, anti-CD40 or anti-, and secreted reporter enzyme levels determined after 48 h. Figure 2a illustrates that in P3HR1 B cells, the CD23a promoter region responds exclusively to IL-4 stimulation as judged by an approximately two-fold increase in reporter gene expression; no other stimulus was effective in provoking transcription from this promoter region. Conversely, the CD23b-regulated reporter construct showed responsiveness to several stimuli (Figure 2b ). IL-4 was again an effective inducer of reporter activity, but anti-
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and anti-CD40 treatments also provoked a robust reporter response.
An essentially identical pattern of results was obtained when tonsillar B cells were analysed. As in the P3HR1 model cell line, transcription of the reporter construct under the control of the CD23a promoter region could be elicited only with IL-4 ( Figure 2c ). By contrast, each of IL-4, anti-and anti-CD40 could activate reporter gene expression under the control of the CD23b proximal promoter fragment, albeit to differing extents (Figure 2d ). In the tonsillar B cells, IL-4 was consistently superior to antior anti-CD40 in terms of capacity to promote CD23b-regulated reporter gene expression. Low levels of CD23 expression were consistently noted for anti--treated cells, and to rule out the possibility that these reflected enhanced proteolytic cleavage of CD23, levels of sCD23 in culture supernatants was measured. The levels of sCD23 in control and anti--treated culture supernatants, as measured by ELISA, were essentially identical (11.12 ng/ml in unstimulated cell supernatants, 13.06 in anti--stimulated cell supernatants). Figure 3 shows a flow cytometric analysis of CD23 expression in the B cell population to show that the transfection regime had no significant effect upon the cells in terms of expression of the endogenous CD23 gene.
Deletion mutant analysis of the CD23a proximal promoter region
Analysis of the 5Ј sequences flanking the CD23a and CD23b transcriptional start sites reveals the presence of a number of sequences which conform to the minimum requirements for binding of particular transcriptional regulatory proteins (see Figure 1) . We sought to determine which of these sites was functional in, for example, IL-4-driven promoter activation by constructing a set of deletion mutants. Tonsillar B cells were transfected with full length and deletion mutant forms of the CD23a proximal promoter then challenged with IL-4, anti-CD40 or anti-prior to analysis of reporter gene expression ( Figure 4 ). The data clearly show that only the full-length promoter construct retained IL-4-sensitive function, with deletion of the first STAT6 binding site (p⌬S6-1 mutant and all others) resulting in a drop in IL-4-driven reporter gene expression to baseline levels ( Figure 4a ). These data suggest that this first STAT6 binding site is mandatory for IL-4-mediated CD23a gene expression. Neither anti-CD40 (Figure 4b ) nor anti-stimulation (Figure 4c ) of transfected tonsillar B cells provoked SEAP expression, either for full length or deletion mutants. Moreover, no enhancement of reporter activity in any deletion mutant was noted for any stimulus, suggesting that there are no negative regulatory sequences influencing the activity of antigen receptor or CD40 signalling in this region of the CD23 promoter. Figure 1 illustrates that the CD23b proximal promoter region possesses elements that could serve to bind transcriptional regulatory proteins. Freshly-isolated tonsillar B cells were transfected with full length or deletion mutants of the CD23b proximal promoter, stimulated, and reporter levels measured after 48 h. IL-4 induced robust expression of the full-length promoter fragment, and this was maintained even when the first STAT6 (p⌬S6-1) and NF-B sites (p⌬B) were deleted from the elements regulating reporter expression. Only when the second STAT6 was deleted was IL-4-sensitivity lost. Anti-CD40 stimulation induced moderate reporter activation in the full length and p⌬S6-1 constructs, with the latter showing an elevated level of activity. However, deletion of the B site in the CD23b promoter completely abolished the moderate and elevated responses made following anti-CD40 challenge. These data suggest that the B site is required for expression of CD23 driven by CD40 ligation, an interpretation entirely consistent with the known ability of CD40 to regulate NF-B activation in B lymphocytes. Finally, anti-stimulation of transfected B cells gave a moderate and somewhat variable output in terms of reporter gene expression. In this instance, the low level of anti--driven transcriptional response was retained following deletion of the B site and was lost only upon deletion of AP1 sites very close to the transcriptional start site for CD23b. The data are consistent with the view that anti-stimulation drives CD23b expression via a mechanism which is largely independent of NF-B activation.
Deletion mutant analysis of CD23b proximal promoter function

Discussion
The data of this report indicate that the isolated proximal promoter regions of the CD23a and CD23b isoforms show different patterns of response to exogenous stimulation in normal human tonsillar B lymphocytes. The CD23a promoter is activated only by IL-4, a process apparently dependent upon the most 5Ј of two STAT6 sites in the promoter, while the CD23b promoter region can be activated by a range of stimuli whose activities can be traced to particular transcription factor binding sites. The EBV status of the B cells seems to play little role in the transcriptional regulatory properties of these short elements, since the pattern of results obtained using transiently-transfected P3HR1 lymphoma cells, an EBV super-infected subline of Jijoye cells, was essentially identical to that obtained using tonsillar B cells.
IL-4 is the most potent inducer of CD23 expression in human B cells, so it is unsurprising that both isoform promoters, in isolation, responded positively when the transfected cells were challenged with this cytokine. Interestingly, the STAT6 binding site most distal to the transcription initiation site for the CD23a proved to be indispensable for IL-4 responsiveness. Moreover, the more proximal site, which lies adjacent to a NF-B site, could not by itself support IL-4-driven expression of the SEAP reporter gene. The B site was itself unresponsive in cells treated with anti-CD40 antibodies, suggesting that this region of the CD23a promoter is silent with regard to signals delivered via cell surface receptors. BSAP is the protein product of the PAX-5 gene, 18 and has an important role in transcription of B cell specific genes. 19 BSAP also regulates B cell development at the pro-B to pre-B transition 20 and controls B cell proliferation and immunoglobulin secretion in response to mitogens. 21 The data of Figure 4 suggest that the BSAP site in the CD23a promoter is insensitive to anti-stimulation either in the full-length construct, or in the deletion mutant in which the BSAP element is the principal remaining transcription factor binding site. It is therefore unlikely that anti--driven proliferative responses promote enhancement of autocrine growth by soluble CD23 via a BSAP-dependent mechanism. Finally, BSAP is frequently over-expressed in certain tumours, notably lymphoplasmacytoid lymphoma, due to the t(9;14)(p13;q32) translocation. 22 It is possible that over-expression of BSAP could give rise to the over-expression of CD23 in such tumours, with increased likelihood of autocrine tumour growth as a result of increased availability of soluble CD23. 23, 24 The CD23b promoter shows a much wider range of responsiveness to extracellular stimuli. In this case, deletion of both STAT6 binding sites was required before IL-4-responsiveness was lost. Moreover, no diminution of IL-4-driven reporter gene expression was noted in the p⌬S6-1 mutant, suggesting that one STAT6 binding site is sufficient to allow maximal gene expression to occur. However, it is not possible to rule out a regulatory role for the more 5Ј of the STAT6 sites in the absence of a mutagenesis-based analysis of the two STAT6 sites. The B site in the CD23b promoter was necessary to allow CD40-mediated signalling to drive CD23 expression. This is consistent with the data from many laboratories which demonstrate the capacity of CD40 ligation to promote CD23 expression in normal and neoplastic B cells. [25] [26] [27] [28] [29] This result also underscores the unresponsiveness of the CD23a promoter to stimuli other than IL-4. Thus, anti-CD40 treatment causes CD23 protein production at the whole-cell level and drives CD23b-regulated reporter gene expression, but fails to stimulate CD23a promoter activity. CD40 signalling is linked to Jak3 activation 30 and to stimulation of the SAPK pathway, 31 with ultimate effects upon c-jun phosphorylation. However, there appears to be no role for AP1 family members in CD40-mediated CD23b expression since deletion of the B site resulted in loss of anti-CD40-driven reporter expression. Anti-stimulation of CD23b-regulated reporter expression was variable in our analyses, and appeared to be lost only after deletion of the second of the two putative AP1 sites present in this promoter region. This result suggests that AP1 family members may play a role in regulating CD23b expression via this element.
The work presented in this report uses isolated elements of the CD23a and CD23b upstream regions, and confirms that the CD23a regulatory sequences show less sensitivity to external stimuli than the CD23b promoter, at least in B cells. The mechanisms of interaction of regulated transcription factors binding at the various sites in the two promoters with the basal transcription machinery remain to be resolved.
Materials and methods
Materials
Tissue culture supplies including RPMI-1640 medium, foetal calf serum, antibiotics, glutamine and disposable plasticware, were from Life Technologies (Paisley, Scotland, UK). Aprotinin, leupeptin, DTT, PMSF and goat anti-human -chain (F ab Ј 2 fragment) were obtained from Sigma (UK). The pSEAP (secreted alkaline phosphatase) plasmids and associated reagents were obtained from Clontech (Cambridge, UK). Synthetic oligonucleotides were obtained from MWG Biotech (Milton Keynes, UK), and [ 
Reporter plasmid assembly and mutagenesis
The CD23a and CD23b proximal promoter regions were amplified from human genomic DNA using appropriate primer pairs bearing extensions with KpnI and Bgl II restriction sites to facilitate subsequent directional cloning into the pSEAP-basic vector. Deletion mutants with defined end-points in the 5Ј flanking sequence were generated by PCR using a common 3Ј antisense oligonucleotide as the reverse primer and an oligonulcleotide defining the 5Ј end point extended contain a KpnI site as the forward primer. Amplicons were purified and directionally cloned into the pSEAP-Enhancer vector, and their identity verified by restriction analysis and by automated DNA sequencing (data not shown). All oligonucleotides used for insert generation and deletion are shown in Table 1 .
Cell isolation, culture and transfection studies
High density, quiescent human B cells were prepared from a single cell suspension derived from tonsils obtained from routine surgery as described previously, 32, 33 with ethical approval and informed consent. Briefly, mononuclear cells obtained from Ficoll-Hypaque gradients were washed thrice and pelleted with AET-SRBC for 5 minutes at 90 g. The non-rosetted, B cell enriched population was centrifuged through a discontinuous percoll gradient at 1000 g for 30 min and high density, quiescent B cells removed from the 1.09 g/ml to 1.08 g/ml interface. The cells were washed three times, the final wash being in complete medium (RPMI-1640 medium supplemented with 10 2 units/ml penicillin, 100 g/ml streptomycin, 10% (v/v) FCS and 5 mM fresh glutamine). The B lymphoid cell line P3HR1 was maintained in RPMI-1640 medium supplemented with 10 2 units/ml penicillin, 100 g/ml streptomycin and 10% (v/v) FCS and 5 mM glutamine (complete medium) at 37°C in a humid 5% CO 2 atmosphere.
For transfection, cells were harvested from log-phase cultures, washed twice in serum-free medium and resuspended at 6.25 × 10 6 /ml in serum-free medium. Aliquots of 0.8 ml (ie, 5 × 10 6 cells) were added to chilled electroporation cuvettes containing 40 g of the desired Table 1 Synthetic oligonucleotides used for PCR-mediated generation of promoter constructs
Plasmid name
Primer sequence
5 Ј -ggcggtacctggtgtgagtaaggaggtga -3Ј CD23b ⌬AP1-1 5 Ј -ggcggtaccttttctgattcaacaccctc -3Ј CD23b ⌬AP1-2 5 Ј -ggcggtaccgcaatagagtcagaggccaa -3Ј CD23b (common reverse primer) 5Ј -gcagatctgcactcaccctggcttgg -3Ј
Synthetic oligonucleotides (from MWG Biotech, Milton Keynes, UK) were designed to amplify defined sequences of the CD23a and CD23b proximal promoter regions, and to bear restriction enzyme sites (shown in italics) to facilitate directional cloning into the pSEAP-Enhancer reporter vector. PCR products were cloned and fidelity of amplification checked by automated DNA sequencing.
reporter plasmid and 20 g of the pLW2 plasmid and then electroportated for 10 s at 350 V/960 F. 32, 33 (pLW2 comprises a CAT reporter gene under the control of the Herpes Simplex virus 1 thymidine kinase promoter, and serves as a control for transfection efficiency.) After transfection, cells were rested for 1 h in complete medium, then divided into equal aliquots for culture in the presence or absence of appropriate stimuli as noted in individual figure legends.
After culture, aliquots of culture supernatant were heat-treated (65°C for 30 min) then assessed for the presence of alkaline phosphatase activity according to the manufacturer's instructions. Activity of the pLW2 control vector was determined in heat-treated cell extracts by incubation with acetyl coenzyme A and 0.025 Ci [ 14 C]-chloramphenicol, followed by extraction of products with ethyl acetate and thin layer chromatographic separation. The data were normalised for levels of CAT reporter activity, and the levels of specific SEAP reporter activity are presented as relative reporter activity compared to unstimulated cells transfected with pCD23. All data figures show results representative of a minimum of three independent transfections of cell line or tonsillar tissue material.
